DaVita
DVA
#1816
Rank
HK$90.28 B
Marketcap
HK$1,407
Share price
1.26%
Change (1 day)
43.02%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): HK$97.53

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$97.93. In 2025 the company made an earnings per share (EPS) of HK$79.41 a decrease over its 2024 EPS that were of HK$86.55.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$97.5322.81%
2025HK$79.41-8.25%
2024HK$86.5544.94%
2023HK$59.7227.26%
2022HK$46.93-35.56%
2021HK$72.8244.1%
2020HK$50.5419.7%
2019HK$42.22540.48%
2018HK$6.59-76.07%
2017HK$27.54-19.31%
2016HK$34.14242.52%
2015HK$9.97-62.87%
2014HK$26.8413.43%
2013HK$23.668.45%
2012HK$21.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$194.85 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$95.50-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$204.97 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$16.61-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA